'Dietary Arginine Supplementation Affects Intestinal Function by Enhancing Antioxidant Capacity of a Nitric Oxide–Independent Pathway in Low-Birth-Weight Piglets
Ping Zheng,Yi Song,Yihang Tian,Hao Zhang,Bing Yu,Jun He,Xiangbing Mao,Jie Yu,Yuheng Luo,Junqiu Luo,Zhiqing Huang,Gang Tian,Hong Chen,Daiwen Chen
DOI: https://doi.org/10.1093/jn/nxy198
2018-01-01
Abstract:Background: Low-birth-weight (LBW) neonates are susceptible to intestinal dysfunction. Furthermore, the antioxidant capacity of LBVV neonates is significantly lower compared with that of normal-birth-weight (NBVV) neonates both at birth and at weaning. In LBW neonates, dietary supplementation with arginine has shown beneficial effects on intestinal function. Objective: The present study explored the potential mechanisms of arginine-induced protective effects against intestinal dysfunction in LBW piglets. Methods: Forty 4-d-old LBW piglets [body vveight (BM: 1.05 +/- 0.04 kg] (Large White x Landrace) were assigned to 4 treatments and artificially fed a whole-milk powder and whey protein concentrate based diet (containing 0.65% arginine) either not supplemented with arginine (LBWC) or supplemented with 0.5%, 1.0%, or 1.5% L-arginine for 21 d. In addition, 10 NBW siblings (,BW: 1.96 +/- 0.03 kg) vvere selected and fed the basal diet. Growth performance, intestinal morphology, mRNA expression of tight junction protein, redox-sensitive genes and nitric oxide (NO) synthase, cytokines, and redox indexes were determined. Data were subjected to 1-factor ANOVA. Results: LBW piglets exhibited poorer growth performance 129.9%), lower Claudinl mRNA level 163.6%), lower antioxidant capacity (22.9 similar to 24.3%), and higher jejunum interleukin 1 (IL-1) concentration (18.8%) compared with NBW piglets. Dietary supplementation with 0.5% and 1.0% Larginine significantly enhanced daily BW gain of LBW piglets by 13.6% and 18.2%, respectively. Compared with LBWC, dietary supplementation with 1.0% L-arginine increased the serum insulin concentration (32.2%) and villus height in the jejunum 112.2%) and ileum (20.5%). In the jejunum, the mRNA levels for Claudinl (105%) and glutathione peroxidase (36%) were higher, and the concentrations of IL-1 (31.7%) and tumor necrosis factor alpha (TNF-alpha) (30%) were lower in arginine-treated piglets than in the LBWC group. However, NO synthase activity and NO concentration in the jejunum of LBW piglets were not influenced by L-arginine supplementation. Conclusion: The results suggested that supplementation with 1.0% L-arginine not only promoted growth performance and improved intestinal functions in LBW piglets but also improved intestinal barrier functions and enhanced antioxidant capacity by an NO-independent pathway.